Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BDSX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BDSX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Biodesix Inc

BDSX
Current price
0.31 USD +0.0032 USD (+1.05%)
Last closed 0.31 USD
ISIN US09075X1081
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 44 760 344 USD
Yield for 12 month -82.06 %
1Y
3Y
5Y
10Y
15Y
BDSX
21.11.2021 - 28.11.2021

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado. Address: 919 West Dillon Road, Louisville, CO, United States, 80027

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.80 USD

P/E Ratio

Dividend Yield

Financials BDSX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BDSX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+71 323 000 USD

Last Year

+49 087 000 USD

Current Quarter

+17 958 000 USD

Last Quarter

+20 429 000 USD

Current Year

+55 750 000 USD

Last Year

+36 077 000 USD

Current Quarter

+14 255 000 USD

Last Quarter

+16 087 000 USD
EBITDA -26 577 000 USD
Operating Margin TTM -50.47 %
Price to Earnings
Return On Assets TTM -23.33 %
PEG Ratio
Return On Equity TTM -1 454.41 %
Wall Street Target Price 1.80 USD
Revenue TTM 74 463 000 USD
Book Value 0.076 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 21.20 %
Dividend Yield
Gross Profit TTM 58 362 000 USD
Earnings per share -0.27 USD
Diluted Eps TTM -0.27 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -54.28 %

Stock Valuation BDSX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.22
Price Sales TTM 0.60
Enterprise Value EBITDA -2.72
Price Book MRQ 4.19

Technical Indicators BDSX

For 52 Weeks

0.17 USD 2.04 USD
50 Day MA 0.33 USD
Shares Short Prior Month 5 259 810
200 Day MA 0.95 USD
Short Ratio 0.23
Shares Short 4 907 456
Short Percent 7.07 %